Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: A randomized, open-labeled trial

« Previous Next »Psychiatry Research
Volume 169, Issue 2 , Pages 118-123, 30 September 2009

Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: A randomized, open-labeled trial☆

Eun-Ho Kang
- Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
In-Soo Lee
- Department of Psychiatry, Semin Mental Hospital, Yeoju, South Korea
Sang-Keun Chung
- Department of Psychiatry, Chonbuk National University Medical School, Jeonju, South Korea
Sang-Yeol Lee
- Department of Psychiatry, School of Medicine, Wonkwang University, Iksan, South Korea
Eui-Jung Kim
- Department of Psychiatry, College of Medicine, Ewha Womans University, Seoul, South Korea
Jin-Pyo Hong
- Department of Psychiatry, College of Medicine, Asan Medical Center, Ulsan University, Seoul, South Korea
Kang-Seob Oh
- Department of Psychiatry, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, South Korea
Jong-Min Woo
- Department of Neuropsychiatry and Stress Research Institute, Seoul Paik Hospital, Inje University, School of Medicine, Seoul, South Korea
Seonwoo Kim
- Biostatistics Unit of Samsung Biomedical Research Institute, Seoul, South Korea
Joo-Eon Park
- Department of Psychiatry, Keyo Hospital, Euiwang, South Korea
Bum-Hee Yu
- Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
- Corresponding author. Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon-Dong 50, Gangnam-Gu, Seoul, South Korea 135-710. Tel.: +82 2 3410 3583; fax: +82 2 3410 6957.